Gastrointestinal nematode infection increases organophosphate toxicity in rats

Toxicology Letters

Volumn 180, Issue 1, 2008, Pages 33-37

  Farid, Ayman Samir ^a,b   Horii, Yoichiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Benha University   (Egypt)

Author keywords

Acetyl cholinesterase; Chlorpyrifos oxon; Nippostrongylus brasiliensis; Paraoxon; Paraoxonase 1

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE 1; CHLORPYRIFOS; INTERLEUKIN 1; INTERLEUKIN 6; PARAOXON; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FECES ANALYSIS; GASTROINTESTINAL INFECTION; INFLAMMATION; MALE; NEMATODIASIS; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ADMINISTRATION, CUTANEOUS; ANIMALS; ARYLDIALKYLPHOSPHATASE; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; INSECTICIDES; INTESTINAL DISEASES, PARASITIC; MICE; NIPPOSTRONGYLUS; PARAOXON; PARASITE EGG COUNT; PARASITIC DISEASES, ANIMAL; RATS; RATS, WISTAR; STRONGYLIDA INFECTIONS;

NIPPOSTRONGYLUS BRASILIENSIS; RATTUS; RATTUS NORVEGICUS;

EID: 47049113943     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.05.016     Document Type: Article

References (37)

1. Beltowski J., Jamroz-Wiśniewska A., Borkowska E., and Wójcicka G. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Pharmacological Research 51 (2005) 523-532
2. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., and Hotez P.J. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367 (2006) 1521-1532
3. Cappello M. Global health impact of soil-transmitted nematodes. The Pediatric Infectious Disease Journal 23 (2004) 663-664
4. Cole T.B., Walter B.J., Shih D.M., Tward A.D., Lusis A.J., Timchalk C., Richter R.J., Costa L.G., and Furlong C.E. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenetics and Genomics 15 (2005) 589-598
5. Costa L.G., McDonald B.E., Murphy S.D., Omenn G.S., Richter R.J., Motulsky A.G., and Furlong C.E. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. Toxicology and Applied Pharmacology 103 (1990) 66-76
6. Costa L.G., Cole T.B., Jarvik G.P., and Furlong C.E. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annual Review of Medicine 54 (2003) 371-392
7. Costa L.G., Richter R.J., Li W.F., Cole T., Guizzetti M., and Furlong C.E. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8 (2003) 1-12
8. Costa L.G., Cole T.B., and Furlong C.E. Paraoxonase (PON1): from toxicology to cardiovascular medicine. Acta Biomedicine 76 Suppl. 2 (2005) 50-57
9. Costa L.G., Vitalone A., Cole T.B., and Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochemical Pharmacology 69 (2005) 541-550
10. De Silva H.J., Samarawickrema N.A., and Wickremasinghe A.R. Toxicity due to organophosphorus compounds: what about chronic exposure?. Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (2006) 803-806
11. Durrington P.N., Mackness B., and Mackness M.I. Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 21 (2001) 473-480
12. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7 (1961) 88-95
13. Farid A.S., Nakahara K., Murakami N., Hayashi T., and Horii Y. Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats. The American Journal of Tropical Medicine and Hygiene 78 (2008) 770-776
14. Feingold K.R., Memon R.A., Moser A.H., and Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139 (1998) 307-315
15. Furlong C.E. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. Journal of Biochemical and Molecular Toxicology 21 (2007) 197-205
16. Grigg M.E., Tang L., Hussein A.S., and Selkirk M.E. Purification and properties of monomeric (G1) forms of acetylcholinesterase secreted by Nippostrongylus brasiliensis. Molecular and Biochemical Parasitology 90 (1997) 513-524
17. Haley R.W., Billecke S., and La Du B.N. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicology and Applied Pharmacology 157 (1999) 227-233
18. Harcus Y.M., Parkinson J., Fernández C., Daub J., Selkirk M.E., Blaxter M.L., and Maizels R.M. Signal sequence analysis of expressed sequence tags from the nematode Nippostrongylus brasiliensis and the evolution of secreted proteins in parasites. Genome Biology 5 (2004) R39
19. Hayes K.S., Bancroft A.J., and Grencis R.K. Immune-mediated regulation of chronic intestinal nematode infection. Immunological Reviews 201 (2004) 75-88
20. Horii Y., Khan A.I., and Nawa Y. Persistent infection of Strongyloides venezuelensis and normal expulsion of Nippostrongylus brasiliensis in Mongolian gerbils, Meriones unguiculatus, with reference to the cellular responses in the intestinal mucosa. Parasite Immunology 15 (1993) 175-179
21. Hussein A.S., Chacon M.R., Smith A.M., Tosado-Acevedo R., and Selkirk M.E. Cloning, expression, and properties of a nonneuronal secreted acetylcholinesterase from the parasitic nematode Nippostrongylus brasiliensis. The Journal of Biological Chemistry 274 (1999) 9312-9319
22. Ishikawa N., Horii Y., Oinuma T., Suganuma T., and Nawa Y. Goblet cell mucins as the selective barrier for the intestinal helminths: T-cell-independent alteration of goblet cell mucins by immunologically 'damaged' Nippostrongylus brasiliensis worms and its significance on the challenge infection with homologous and heterologous parasites. Immunology 81 (1994) 480-486
23. Ishiwata K., Nakao H., Nakamura-Uchiyama F., and Nawa Y. Immune-mediated damage is not essential for the expulsion of Nippostrongylus brasiliensis adult worms from the small intestine of mice. Parasite Immunology 24 (2002) 381-386
24. Jaouad L., de Guise C., Berrougui H., Cloutier M., Isabelle M., Fulop T., Payette H., and Khalil A. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 185 (2006) 191-200
25. Kumon Y., Suehiro T., Ikeda Y., and Hashimoto K. Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6. Life Sciences 73 (2003) 2807-2815
26. Lee D.L. Why do some nematode parasites of the alimentary tract secrete acetylcholinesterase?. International Journal for Parasitology 26 (1996) 499-508
27. Lewis P.J., Lowing R.K., and Gompertz D. Automated discrete kinetic method for erythrocyte acetylcholinesterase and plasma cholinesterase. Clinical Chemistry 27 (1981) 926-929
28. Li W.F., Costa L.G., and Furlong C.E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. Journal of Toxicology and Environmental Health 40 (1993) 337-346
29. Li W.F., Furlong C.E., and Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicology Letters 76 (1995) 219-226
30. Li W.F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Tward A., Lusis A.J., and Furlong C.E. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10 (2000) 767-779
31. Mackness B., Durrington P.N., and Mackness M.I. Human serum paraoxonase. General Pharmacology 31 (1998) 329-336
32. Rochu D., Chabrière E., and Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 233 (2007) 47-59
33. Russell W.S., Henson S.M., Hussein A.S., Tippins J.R., and Selkirk M.E. Nippostrongylus brasiliensis: infection induces upregulation of acetylcholinesterase activity on rat intestinal epithelial cells. Experimental Parasitology 96 (2000) 222-230
34. Sanderson B.E., and Ogilvie B.M. A study of acetylcholinesterase throughout the life cycle of Nippostrongylus brasiliensis. Parasitology 62 (1971) 367-373
35. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., and Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (1998) 284-287
36. Stepek G., Buttle D.J., Duce I.R., and Behnke J.M. Human gastrointestinal nematode infections: are new control methods required?. International Journal of Experimental Pathology 87 (2006) 325-341
37. Tang J., and Chambers J.E. Detoxication of paraoxon by rat liver homogenate and serum carboxylesterases and A-esterases. Journal of Biochemical and Molecular Toxicology 13 (1999) 261-268